Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Sage Therapeutics, Inc. | Director | Common Stock | 3K | $57.8K | $19.27 | Aug 9, 2023 | Direct |
Sage Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 12.5K | Jun 10, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SAGE | Sage Therapeutics, Inc. | Jun 10, 2024 | 1 | $0 | 4 | Jun 11, 2024 | Director |
SAGE | Sage Therapeutics, Inc. | Aug 9, 2023 | 1 | $37.3K | 4 | Aug 11, 2023 | Director |
SAGE | Sage Therapeutics, Inc. | Jun 15, 2023 | 1 | $0 | 4 | Jun 16, 2023 | Director |
SAGE | Sage Therapeutics, Inc. | May 9, 2023 | 1 | $50.5K | 4 | May 11, 2023 | Director |
SAGE | Sage Therapeutics, Inc. | Jun 16, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
SAGE | Sage Therapeutics, Inc. | Jan 4, 2022 | 1 | $0 | 4 | Jan 5, 2022 | Director |
SAGE | Sage Therapeutics, Inc. | Jun 10, 2021 | 1 | $0 | 4 | Jun 11, 2021 | Director |